SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SANOFI INDIA

BSE: 500674 29 Jun 2025
Healthcare
₹ 6035
Sanofi India Ltd specializes in Pharmaceuticals within the Healthcare sector.

SANOFI INDIA - Share Price & Details

Market Cap
₹13,834
High /Low
7,600 / 4,146
Stock P/E
31.3
Book Value
₹374.0
Dividend Yield
1.95
ROCE
49.2
ROE
₹47.1
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹26.7
Debt
19.3
CMP / FCF
NA
Debt to equity
₹0.02
NP Ann
413
High price all time
7,600
Piotroski score
₹6.0
Graham Number
1,230
No. Eq. Shares
2.3
Net CF
₹-111
Net profit
413
Price to book value
16.0
Interest Coverage
₹314.0
Low price all time
399.0
Industry PE
32.0
Reserves
₹838
Free Cash Flow
₹426

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
SANOFI INDIA LTD5392.01195.05359.051.8913,83431.3
ALIVUS LIFE SCIENCES LIMITED6596.331418.686495.4511.551224125.2
GRANULES INDIA LTD.NANANANA1206425.2

Peer Comparison Chart


About SANOFI INDIA

Sanofi India Ltd, with Security Code 500674, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Has Sanofi India declared dividend?

(06 Jun 2025)
Yes, Sanofi India Ltd has declared a dividend of 1170%, amounting to ₹117 per share, with an ex-date of April 25, 2025.
Read more →

Sanofi India ropes in Sudipta Chakraborty as Head of Legal, India

(27 May 2025)
Mumbai: Sanofi India has announced the appointment of Sudipta Chakraborty as the Head of Legal, India, effective from 2nd June 2025.
Read more →

Sanofi India appoints Sudipta Chakraborty as Head of Legal

(27 May 2025)
Chakraborty brings over two decades of legal experience across sectors, including pharmaceuticals, manufacturing, and conglomerate...
Read more →

Sanofi India Limited's (NSE:SANOFI) Stock Is Going Strong: Have Financials A Role To Play?

(19 May 2025)
Sanofi India's (NSE:SANOFI) stock is up by a considerable 18% over the past three months. We wonder if and what role...
Read more →

Sanofi India posts 27% growth in operating profits in Q1 2025

(17 May 2025)
Sanofi India Limited (SIL) declared its financial results for the quarter ended on March 31st, 2025. The Company has delivered net sales...
Read more →

Sanofi India consolidated net profit declines 12.52% in the March 2025 quarter

(15 May 2025)
Net profit of Sanofi India declined 12.52% to Rs 119.50 crore in the quarter ended March 2025 as against Rs 136.60 crore during the previous quarter ended...
Read more →